Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Danesi

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factorsA Gennari, B Salvadori, S Donati, et al.
Journal of the Neurological Sciences|February 7, 1998
Chronic administration of suramin induces neurotoxicity in ratsA Di Paolo, R Danesi, F Innocenti, et al.
Cancer Treatment Reviews|May 24, 2017
Critical focus on mechanisms of resistance and toxicity of m-TOR inhibitors in pancreatic neuroendocrine tumorsL Antonuzzo, M Del Re, V Barucca, et al.
British Journal of Cancer|June 1, 2001
Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cellsA Di Paolo, R Danesi, S Caputo, et al.
Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samplesE Giovannetti, A C Laan, E Vasile, et al.
Cancer|August 3, 1999
Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinomaA Falcone, A Antonuzzo, R Danesi, et al.
British Journal of Cancer|November 1, 1993
Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membraneR Danesi, S Del Bianchi, P Soldani, et al.
Oncology|November 5, 1999
Infusions of fluorouracil and leucovorin: effects of the timing and semi-intermittency of drug deliveryA Falcone, G Allegrini, A Antonuzzo, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1997
Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatmentL Fatigante, F Ducci, F Cartei, et al.
Oncology|July 28, 2001
5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: a randomized phase II study in metastatic colorectal cancerA Falcone, G Allegrini, G Masi, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factorsA Gennari, B Salvadori, S Donati, et al.
Journal of the Neurological Sciences|February 7, 1998
Chronic administration of suramin induces neurotoxicity in ratsA Di Paolo, R Danesi, F Innocenti, et al.
Cancer Treatment Reviews|May 24, 2017
Critical focus on mechanisms of resistance and toxicity of m-TOR inhibitors in pancreatic neuroendocrine tumorsL Antonuzzo, M Del Re, V Barucca, et al.
British Journal of Cancer|June 1, 2001
Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cellsA Di Paolo, R Danesi, S Caputo, et al.
Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samplesE Giovannetti, A C Laan, E Vasile, et al.
Cancer|August 3, 1999
Suramin in combination with weekly epirubicin for patients with advanced hormone-refractory prostate carcinomaA Falcone, A Antonuzzo, R Danesi, et al.
British Journal of Cancer|November 1, 1993
Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membraneR Danesi, S Del Bianchi, P Soldani, et al.
Oncology|November 5, 1999
Infusions of fluorouracil and leucovorin: effects of the timing and semi-intermittency of drug deliveryA Falcone, G Allegrini, A Antonuzzo, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1997
Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatmentL Fatigante, F Ducci, F Cartei, et al.
Oncology|July 28, 2001
5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: a randomized phase II study in metastatic colorectal cancerA Falcone, G Allegrini, G Masi, et al.
Pageof 16